Skip to content

Lay-user Trial of the iGlucose Blood Glucose Monitoring System

A Lay User Study of the iGlucose, a Device for Self-Monitoring of Blood Glucose (SMBG), Marketed by the Smart Meter Corporation

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT02709707
Enrollment
153
Registered
2016-03-16
Start date
2016-03-31
Completion date
2016-06-30
Last updated
2016-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes Mellitus

Keywords

Diabetes, Blood Sugar

Brief summary

Evaluation of the iGlucose Blood Glucose Monitoring System in the hands of lay users

Detailed description

A non-randomized, prospective study of recruited subjects with diabetes. Subjects will include those with type I or type II diabetes of various duration and those who are naive to self-testing of blood glucose. Subjects will use provided instructions-for-use to undergo self-training on the use of the device and will then self-test their blood glucose level. Results will be compared to those obtained by a lab glucose analyzer.

Interventions

Sponsors

Nina Peled
Lead SponsorINDUSTRY

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
12 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* Be 12 years of age and older * Have pre-existing diagnosis of diabetes * Be able to read and understand English * Agree to participate in the study * Be able and willing to provide informed consent

Exclusion criteria

* Do not meet Inclusion Criteria * With Hemophilia or any other bleeding disorder * With any condition which in the opinion of the Investigator may place the subject or site staff at excessive risk * With physical condition/limitation preventing the use of SMBG on their own

Design outcomes

Primary

MeasureTime frame
Accuracy of blood glucose measurements as performed by lay users10 minutes to produce self blood result and to perform lab comparative method

Secondary

MeasureTime frame
Assessment by lay users of the ease of use of the iGlucose Blood Glucose Monitoring System2 -3 hours of going through a self-training session and producing an assessment

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026